Ardsley Advisory Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.28M | Buy |
400,000
+100,000
| +33% | +$1.82M | 0.96% | 32 |
|
|
2025
Q1 | $5.95M | Buy |
+300,000
| New | +$5.95M | 1.14% | 24 |
|
|
2020
Q4 | – | Sell |
-94,100
| Closed | -$225K | – | 105 |
|
|
2020
Q3 | $225K | Sell |
94,100
-3,000
| -3% | -$7.17K | 0.04% | 102 |
|
|
2020
Q2 | $285K | Buy |
97,100
+22,500
| +30% | +$66K | 0.06% | 96 |
|
|
2020
Q1 | $215K | Hold |
74,600
| – | – | 0.08% | 73 |
|
|
2019
Q4 | $298K | Sell |
74,600
-31,900
| -30% | -$127K | 0.05% | 100 |
|
|
2019
Q3 | $474K | Buy |
106,500
+3,892
| +4% | +$17.3K | 0.11% | 76 |
|
|
2019
Q2 | $397K | Buy |
102,608
+41,308
| +67% | +$160K | 0.06% | 86 |
|
|
2019
Q1 | $233K | Buy |
61,300
+11,300
| +23% | +$43K | 0.04% | 100 |
|
|
2018
Q4 | $120K | Sell |
50,000
-50,000
| -50% | -$120K | 0.03% | 87 |
|
|
2018
Q3 | $621K | Buy |
100,000
+20,000
| +25% | +$124K | 0.08% | 77 |
|
|
2018
Q2 | $361K | Buy |
+80,000
| New | +$361K | 0.05% | 113 |
|